LifeNet and DePuy Synthes Launch VertiGraft ACIS VG2 Allograft Spacer

By Julie A. Vetalice

LifeNet and DePuy Synthes Launch VertiGraft ACIS VG2 Allograft Spacer

LifeNet Health and DePuy Synthes introduced VertiGraft ACIS® VG2™, the first allograft interbody spacer specifically designed for DePuy Synthes' ACIS instrumentation and available exclusively through DePuy Synthes.

VertiGraft ACIS VG2 allograft

VertiGraft ACIS VG2 allograft

Comprising a cancellous core and cortical endplates, VertiGraft ACIS VG2 is engineered to provide mechanical strength, reduce migration and facilitate early vascularization and bone remodeling. A prospective study found 100% fusion rates after 12 months in 74 ACDF patients while facilitating bone growth and remodeling.

VertiGraft ACIS VG2 is available in multiple footprints, in parallel and lordotic configurations to optimize fit, fill and saggital balance restoration.

"VertiGraft ACIS VG2 brings together the latest in structural allograft technology with state-of-the-art spinal instrumentation," said Heather Pierce, General Manager of Global Spine and General Orthopedics at LifeNet Health. "The result is greater efficiency and flexibility for clinicians and effective healing for patients."

Product Labels: Spinal Fusion

Tags: Product Launch